Eiko Lifesciences Ltd Quarterly Result
Eiko Lifesciences Ltd
NSE: EIKOLIFESCIENCE
Net Profit - Last Quarter
Eiko Lifesciences Ltd Quarterly Results Key Highlights
- The revenue of Eiko Lifesciences Ltd for the Mar '26 is ₹ 18.47 crore as compare to the Dec '25 revenue of ₹ 12.33 crore.
- This represent the growth of 49.8% The ebitda of Eiko Lifesciences Ltd for the Mar '26 is ₹ 2.39 crore as compare to the Dec '25 ebitda of ₹ 2.22 crore.
- This represent the growth of 7.66% The net profit of Eiko Lifesciences Ltd for the Mar '26 is ₹ 1.5 crore as compare to the Dec '25 net profit of ₹ 1.43 crore.
- This represent the growth of 4.9%.
Eiko Lifesciences Ltd Quarterly Results Analysis
Market Price of Eiko Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 12 Jun 2026 | 51.59 |
| 11 Jun 2026 | 51.79 |
| 10 Jun 2026 | 51.51 |
| 09 Jun 2026 | 53.1 |
| 08 Jun 2026 | 52.81 |
| 05 Jun 2026 | 50.14 |
| 04 Jun 2026 | 49.92 |
| 03 Jun 2026 | 51.29 |
| 02 Jun 2026 | 52.95 |
| 01 Jun 2026 | 52.32 |
Historical Revenue of Eiko Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Eiko Lifesciences Ltd
Historical EBITDA of Eiko Lifesciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Eiko Lifesciences Ltd
Historical Net Profit of Eiko Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Eiko Lifesciences Ltd
Eiko Lifesciences Ltd News Hub
Eiko Lifesciences standalone net profit rises 337.50% in the June 2024 quarter
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as agai
Read more
14 Aug 24
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po
Read more
05 Aug 24
Eiko Lifesciences to convene AGM
Eiko Lifesciences announced that the 47th Annual General Meeting (AGM) of the company will be held o
Read more
18 Sept 24
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024. P
Read more
14 Oct 24
Popular Search
About Eiko Lifesciences Ltd
- Eiko Lifesciences Limited was originally incorporated on January 7, 1977, under the name Narendra Investments (Delhi) Limited.
- Later, Company was renamed from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited with effect from June 24, 2021.
- Earlier, Company engaged in sale and purchase of shares and securities.
- At present, Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.
